PLBC vs CARE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 02, 2026
PLBC
57.3
AI Score
VS
It's a Tie!
CARE
57.3
AI Score
Investment Advisor Scores
CARE
57score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | PLBC | CARE | Winner |
|---|---|---|---|
| Net Income | 19.72M | 31.36M | CARE |
| ROE | 7.2% | 7.5% | CARE |
| ROA | 0.9% | 0.6% | PLBC |
| Total Assets | 2.28B | 4.85B | CARE |
| Cash | 135.55M | 105.16M | PLBC |
| Free Cash Flow | 20.82M | 31.81M | CARE |
Relative Price Performance (Last 90 Days)
PLBC 1M: -0.4%
· 3M: +4.9%
CARE 1M: -1.3%
· 3M: -8.4%
Current Technical Phase
PLBC
MarkupHold / add on dips
Price above SMA50, rising 50-day trend (1.9% over 20 days), RSI 52
CARE
MarkdownSell / avoid
Price below a falling SMA50 (slope -2.6%), weak momentum, RSI 44
Fundamentals Snapshot
| Metric | PLBC | CARE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.5 | 11.7 |
| Trailing P/E | 12.1 | 5.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | 0.7% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | 0.5% | 0.6% |
| EPS | 5.08 | 5.80 |
| Dividend Yield | 0.02% | 0.00% |
Frequently Asked Questions
Based on our detailed analysis, PLBC and CARE are evenly matched, both winning 2 key financial metrics each. This is a close call that depends on your specific investment goals.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.